학술논문
Pharmacodynamic Results from Phase 1 Studies of GBT021601, a Next-Generation HbS Polymerization Inhibitor for Treatment of Sickle Cell Disease
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:24-25
Subject
Language
ISSN
0006-4971